New drug for nausea from stomach cancer chemo
Part of Cancer clinical trials.
This trial tests a new form of megestrol acetate to prevent nausea and vomiting caused by chemotherapy in people with advanced stomach cancer who haven't had chemo before. It's for those starting a specific chemo combo that includes a PD-1 inhibitor and CAPOX.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with advanced or recurrent stomach cancer that can't be removed by surgery.
- You have not had chemotherapy before (excluding certain non-cancer treatments).
- Your planned first treatment includes a PD-1 inhibitor (like Tislelizumab) with CAPOX chemotherapy.
- You are generally healthy enough for daily activities (ECOG score 0 or 1) and expected to live at least 6 months.
- You have adequate organ function (blood counts, liver and kidney tests, heart function).
- You agree to use effective birth control if needed and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of two anti-nausea drugs (fosrolapitant and palonosetron) can better prevent nausea and vomiting caused by Trastuzumab Rezetecan. If you are starting this cancer treatment, you may be able to join.
This study tests a new form of megestrol to prevent nausea and vomiting after your first chemotherapy. It is for people who have never had chemo before and are starting a moderately or highly nauseating treatment.
This trial tests a medication called LY3537021 to see if it can prevent nausea and vomiting caused by certain types of chemotherapy (AC or cisplatin) in people who have not had chemo before. It focuses on patients who are otherwise in fairly good health.
This trial tests a newer form of megestrol acetate (a medication that can help with appetite and weight) given alongside standard chemotherapy and radiation for locally advanced cervical cancer that cannot be removed by surgery. The study aims to see if this combination is safe and effective.
This trial tests a new injection, HSK21542, to see if it can prevent nausea and vomiting caused by strong chemotherapy drugs. It may help people who have never had chemo before.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
Hear when a new Chemotherapy-Induced Nausea and Vomiting (CINV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.